Who we are
Founded in 2011, venBio’s venture funds comprise nearly $1.5 billion of committed capital. We are currently investing out of our fourth fund of approximately $550M committed capital. Our team combines scientific, clinical and operating experience in our investment decisions.
We have always focused on the “Four D’s”, real drugs with real differentiation and real data for real diseases. Our biggest success stories have been companies that have generated strong clinical data for meaningful diseases.